Myricetin 3-galactoside (Synonyms: Myricetin 3-O-β-galactopyranoside, Myricetin 3-O-β-D-galactopyranoside, Myricetin 3-O-galactoside, Myricetin 3-β-D-galactoside) |
Catalog No.GC52049
One-Click Copy Product Info
|
Myricetin 3-galactoside inhibits xanthine oxidase (XO) activity, lipid peroxidation and scavenges the free radical.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 15648-86-9
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Myricetin 3-galactoside is a flavonoid that has been found in M. communis and has diverse biological activities.1,2 It inhibits xanthine oxidase in a cell-free assay when used at a concentration of 100 µg/ml.1 Myricetin 3-galactoside is cytotoxic to K562 cells (IC50 = 220 µg/ml) and inhibits hydrogen peroxide-induced malondialdehyde (MDA) formation in the same cells when used at concentrations of 110, 220, and 440 µg/ml.1 In vivo, myricetin 3-galactoside (0.26 and 0.78 mg/kg) reduces carrageenan-induced paw edema in wild-type but not nos2-/- mice.2 It also reduces formalin-induced paw licking in mice.
1.Hayder, N., Bouhlel, I., Skandrani, I., et al.In vitro antioxidant and antigenotoxic potentials of myricetin-3-o-galactoside and myricetin-3-o-rhamnoside from Myrtus communis: modulation of expression of genes involved in cell defence system using cDNA microarrayToxicol. In Vitro22(3)567-581(2008) 2.de Oliveira Azevedo, A., Campos, J.J., de Souza, G.G., et al.Antinociceptive and anti-inflammatory effects of myricetin 3-O-β-galactoside isolated from Davilla elliptica: Involvement of the nitrergic systemJ. Nat. Med.69(4)487-493(2015)
| Cas No. | 15648-86-9 | SDF | |
| Synonyms | Myricetin 3-O-β-galactopyranoside, Myricetin 3-O-β-D-galactopyranoside, Myricetin 3-O-galactoside, Myricetin 3-β-D-galactoside | ||
| Canonical SMILES | O=C(C(O[C@@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)CO)=C(C2=CC(O)=C(C(O)=C2)O)OC3=CC(O)=C4)C3=C4O | ||
| Formula | C21H20O13 | M.Wt | 480.4 |
| Solubility | DMSO : 50 mg/mL (104.08 mM; Need ultrasonic) | Storage | -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.0816 mL | 10.408 mL | 20.816 mL |
| 5 mM | 416.3 μL | 2.0816 mL | 4.1632 mL |
| 10 mM | 208.2 μL | 1.0408 mL | 2.0816 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)